GeneCast Company
%20.jpg)
GeneCast provides cancer screening, monitoring, precision care and accompanying diagnosis through source technology that amplifies only mutated genes.
Total Funding:
$93.5M
Headquarters:
South Korea
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Technology:
preventive
Last Funding Date:
43188
Investors Number:
8
Founded Date:
42675
Industry:
Health Care